Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




New Technology Deciphers Immune Cell Communication to Predict Immunotherapy Response

By LabMedica International staff writers
Posted on 09 Aug 2025

A healthy immune system depends on complex communication between specialized cell types that detect, alert, and eliminate harmful threats. More...

When these immune signaling pathways break down, the result can be autoimmune disorders, uncontrolled infections, or cancer progression. Cancer cells, in particular, can block or manipulate immune communication to evade detection and resist treatment, making it difficult to predict which patients will respond to immunotherapies. Now, a new technology that allows researchers to “listen in” on this immune cell dialogue could help predict who will benefit from immunotherapy.

A research team, led by the Berlin Institute of Health at Charité (Berlin, Germany), Max Delbrück Center (Berlin, Germany), and collaborators, has developed a new technology that decodes how immune cells interact. This innovation allows researchers to "listen in" on immune cell dialogue, measuring millions of cell-to-cell interactions rapidly and cost-effectively. The tool bridges medicine, computer science, and biology.

The researchers tested the technology in multiple disease contexts, including cancer, viral infections, and autoimmune conditions. They used it to study how immunotherapies influence immune cell communication and mapped dynamic immune networks across tissues in high resolution. Their findings, published in Nature Methods, highlight how this method can track immune behavior and its evolution over time.

These insights pave the way for personalized immunotherapies by predicting which patients will benefit most from treatment. The technology also offers a powerful tool to understand immune coordination in diverse diseases. The team is now partnering with clinical institutions to implement the tool in practice and improve patient outcomes by tailoring therapies more precisely.

Related Links:
Berlin Institute of Health at Charité
Max Delbrück Center


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.